Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Frontiers in Oncology|April 10, 2023
Extranodal marginal zone lymphoma clonotypes are detectable prior to eMZL diagnosis in tissue biopsies and peripheral blood of Sjögren's syndrome patients through immunogeneticsP Martijn Kolijn, Erika Huijser, M Javad Wahadat, et al.Rheumatology (Oxford, England)|November 26, 2009
Type I interferons have no major influence on humoral autoimmunity in rheumatoid arthritisTineke Cantaert, Lisa G van Baarsen, Carla A Wijbrandts, et al.Journal of the American College of Cardiology|September 6, 2014
In vivo imaging of enhanced leukocyte accumulation in atherosclerotic lesions in humansFleur M van der Valk, Jeffrey Kroon, Wouter V Potters, et al.Frontiers in Immunology|November 14, 2018
Rheumatoid Arthritis Patients With Circulating Extracellular Vesicles Positive for IgM Rheumatoid Factor Have Higher Disease ActivityOnno J Arntz, Bartijn C H Pieters, Rogier M Thurlings, et al.Annals of the Rheumatic Diseases|February 11, 2022
Proteogenomic analysis of the autoreactive B cell repertoire in blood and tissues of patients with Sjögren's syndromeMathijs G A Broeren, Jing J Wang, Giulia Balzaretti, et al.Annals of the Rheumatic Diseases|June 21, 2019
Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoireSabrina Pollastro, Paul L Klarenbeek, Marieke E Doorenspleet, et al.The Lancet. Rheumatology|January 17, 2024
Ultra-low doses of rituximab for continued treatment of rheumatoid arthritis (REDO study): a randomised controlled non-inferiority trialLise M Verhoef, Nathan den Broeder, Rogier M Thurlings, et al.Rheumatology (Oxford, England)|March 29, 2024
Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profileTheodoros Ioannis Papadimitriou, Jacqueline M J Lemmers, Arjan P M van Caam, et al.Annals of the Rheumatic Diseases|December 20, 2023
CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletionTheodoros Ioannis Papadimitriou, Prashant Singh, Arjan van Caam, et al.Rheumatology (Oxford, England)|August 19, 2020
Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular riskJudith Wienke, Jorre S Mertens, Samuel Garcia, et al.Pageof 5